Biowarfare is among the many infectious threats to human well-being. In modern times, infections kill about 20% of the world’s population annually. But despite advancing diagnostics and treatments we remain vulnerable. The Ebola outbreak (2013–2015) killed more than 11,000 people, infected almost 30,000, cost several billions of dollars, and exposed ambiguity of authority, assigned roles and accountability as public, private, and non-profit bodies gathered to end a chaotic humanitarian tragedy. Though eventually successful, the global outbreak response was disorderly. The questions before us now are these:  How could the Ebola response help us examine our bioterrorism readiness? What were the big lessons?  How might we apply these findings to improve our military preparedness exercises?